Reduction of HbA1c with dulaglutide in type 2 diabetes (T2D) patients negative, low positive or high positive for GAD antibodies (GADA): a post hoc analysis of AWARD-2,-4 and-5
View/ Open
Published version
Embargoed until: 2222-01-01
Reason: Proof copy - Permanent embargo
Embargoed until: 2222-01-01
Reason: Proof copy - Permanent embargo
Volume
60
Pagination
S68 - S68
ISSN
0012-186X
Metadata
Show full item recordAuthors
Pozzilli, P; Leslie, RD; Peters, A; Buzzetti, R; Shankar, SS; Milicevic, Z; Pavo, I; Lebrec, J; Martin, S; Schloot, NCollections
- Centre for Immunobiology [1098]